I agree that this site is using cookies. You can find further informations here.
X
Tod, Michel
242  results:
Search for persons X
?
1

Outils documentaires et d'étude des interactions médicament..:

Tod, Michel
Actualités Pharmaceutiques.  63 (2024)  636 - p. 28-31 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Therapeutic Drug Monitoring and Pharmacogenetic Testing as ..:

Cuvelier, Elodie ; Khazri, Houda ; Lecluse, Cloé...
Pharmaceuticals.  17 (2023)  1 - p. 21 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Clinical results of the EVESOR trial, a multiparameter phas..:

Varnier, Romain ; Puszkiel, Alicja ; Tod, Michel...
Cancer Chemotherapy and Pharmacology.  91 (2023)  5 - p. 361-373 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Evaluation of Renal Impairment Influence on Metabolic Drug ..:

Tuloup, Vianney ; Goutelle, Sylvain ; Tod, Michel.
Clinical Pharmacokinetics.  62 (2023)  2 - p. 307-319 , 2023
Link: https://doi.org/10.1007/..
 
?
5

A PK-PD model linking biomarker dynamics to progression-fre..:

Puszkiel, Alicja ; You, Benoit ; Payen, Léa...
Cancer Chemotherapy and Pharmacology.  91 (2023)  5 - p. 413-425 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Considering the Oral Bioavailability of Protein Kinase Inhi..:

Le Louedec, Félicien ; Puisset, Florent ; Chatelut, Etienne.
Clinical Pharmacokinetics.  62 (2023)  1 - p. 55-66 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Quantitative Prediction of Adverse Event Probability Due to..:

Tod, Michel ; Rodier, Thomas ; Auffret, Marine
Drug Safety.  45 (2022)  7 - p. 755-764 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Covariate analysis of tusamitamab ravtansine, a DM4 anti‐CE..:

Pouzin, Clemence ; Tod, Michel ; Chadjaa, Mustapha..
CPT: Pharmacometrics & Systems Pharmacology.  11 (2022)  3 - p. 384-394 , 2022
Link: https://doi.org/10.1002/..
 
?
9

Low probability of disease cure in advanced ovarian carcino..:

You, Benoit ; Van Wagensveld, Lilian ; Tod, Michel...
British Journal of Cancer.  127 (2022)  1 - p. 79-83 , 2022
Link: https://doi.org/10.1038/..
 
?
10

Paclitaxel with or without pazopanib for ovarian cancer rel..:

Joly, Florence ; Fabbro, Michel ; Berton, Dominique...
Gynecologic Oncology.  166 (2022)  3 - p. 389-396 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Impact of COVID-19 pandemic on antifungal consumption: a mu..:

Bienvenu, Anne-Lise ; Bestion, Audrey ; Pradat, Pierre...
Critical Care.  26 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
12

Modeled Early Longitudinal PSA Kinetics Prognostic Value in..:

Carrot, Aurore ; Elaidi, Reza-Thierry ; Colomban, Olivier...
Cancers.  14 (2022)  3 - p. 815 , 2022
Link: https://doi.org/10.3390/..
 
?
13

Integrated multiple analytes and semi-mechanistic populatio..:

Pouzin, Clemence ; Gibiansky, Leonid ; Fagniez, Nathalie...
Journal of Pharmacokinetics and Pharmacodynamics.  49 (2022)  3 - p. 381-394 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Population Pharmacokinetics and Dosing Simulation of Vancom..:

Garreau, Romain ; Falquet, Benoît ; Mioux, Lisa...
Antibiotics.  10 (2021)  10 - p. 1228 , 2021
Link: https://doi.org/10.3390/..
 
?
15

Does DDI-Predictor Help Pharmacists to Detect Drug-Drug Int..:

Moreau, Fanny ; Simon, Nicolas ; Walther, Julia...
Metabolites.  11 (2021)  3 - p. 173 , 2021
Link: https://doi.org/10.3390/..
 
1-15